Back to the main directory
Press Release
- EQS-News: Berlin Cures' BC 007 Targets Long COVID: Solid Phase II Trial Progress with Over 50% Patient Recruitment by EQS Group AG
- Net Asset Value(s) by GlobeNewsWire
- Disclosure of trading in own shares from February 26, 2024 to March 1, 2024 by GlobeNewsWire
- SpringWorks Therapeutics Initiates Rolling Submission of New Drug Application to the FDA for Mirdametinib for the Treatment of Children and Adults with NF1-PN by GlobeNewsWire
- Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung Cancer by GlobeNewsWire
- Halfords Group PLC: Holding(s) in Company by EQS Group AG
- EQS-News: Auf der Internorga präsentiert Vectron digitale Lösungen und neue Kassensysteme by EQS Group AG
- TC Energy announces sale of Portland Natural Gas Transmission System by GlobeNewsWire
- iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes by GlobeNewsWire
- ECARX's Global Expansion Driven by Strong R&D and International Accreditations by GlobeNewsWire
- Velcan Holdings: Share buyback program - weekly statement by GlobeNewsWire
- EyePoint Pharmaceuticals Announces Appointment of Ramiro Ribeiro, M.D., Ph.D. as Chief Medical Officer by GlobeNewsWire
- Passage Bio Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Recent Business Highlights by GlobeNewsWire
- Arvinas to Participate in Upcoming Investor Conferences by GlobeNewsWire
- Helius Medical Technologies, Inc. Secures HCPCS Codes for Portable Neuromodulation Stimulator (PoNS®) Mouthpiece and Controller by GlobeNewsWire
- WalkMe to Present at Upcoming Investor Conference by GlobeNewsWire
- Puma Announces a Creative Deal to Unlock Value of its Assets in New Brunswick by GlobeNewsWire
- Notice of Inducement Grants for Kurt Hoff, Lantronix Vice President, Worldwide Sales by GlobeNewsWire
- Tecnoglass to Attend the Raymond James 45th Annual Institutional Investors Conference by GlobeNewsWire
- Ethisphere names Avista as one of the 2024 World’s Most Ethical Companies® for the fifth time by GlobeNewsWire
- Beamr Issues Annual CEO Letter to Shareholders: Highlighting Beamr Cloud Launch, 2023 Financial Results and Achievements and Q2 2024 Upcoming Milestones by GlobeNewsWire
- National Association of Home Builders Names Bridgeland® Master Planned Community of the Year for 2024 by GlobeNewsWire
- EQS-News: Pecan Energies, Betreiber des Deepwater Tano/Cape Three Points (DWT/CTP)-Blocks, schließt Rebranding ab und setzt sich für die Erschließung von Wohlstand für Ghana und darüber hinaus ein by EQS Group AG
- Dalata Hotel Group PLC: TVR-Total Voting Rights by EQS Group AG
- Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort by GlobeNewsWire
- EQS-News: BC 007 von Berlin Cures gegen Long COVID: Fortschritte in Phase-II-Studie – 50 % der Patienten rekrutiert by EQS Group AG
- Trane Technologies Named One of the 2024 World’s Most Ethical Companies® by Ethisphere by BusinessWire
- Déclaration hebdomadaire des transactions sur actions propres du 26 février 2024 au 1 mars 2024 by GlobeNewsWire
- Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results by GlobeNewsWire
- Bridger Aerospace Announces Fleet Deployment to Support Texas Firefighting Efforts by GlobeNewsWire
- Edison issues update on UIL (UTL): Long-term focus, avoiding short-term noise by EQS Group AG
- Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer by GlobeNewsWire
- Healthcare Realty Trust Announces Planned Retirement of Two Directors and 2024 Nominees by GlobeNewsWire
- Probe Gold Announces Acquisition of the Beaufor and McKenzie Break Properties in Val-d’Or, Quebec by GlobeNewsWire
- EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis by GlobeNewsWire
- Ferrari N.V.: Periodic Report on the Buyback Program by GlobeNewsWire
- Verizon Innovative Learning reaches 7 million students nationwide to tackle digital divide by GlobeNewsWire
- Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors by GlobeNewsWire
- C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Germany, Against Critical Oncogenic Proteins by GlobeNewsWire
- PepGen Announces Clearance of CTA by UK Medicines & Healthcare Products Regulatory Agency to Begin CONNECT2-EDO51, a Phase 2 Clinical Trial designed to support potential accelerated approval of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy by GlobeNewsWire
- Mirasol Video Update on Sobek Copper-Gold Project – Highlighting the Recent Strategic Addition of Adjacent Rosita Property in Vicuña District, Chile by GlobeNewsWire
- Apollomics Appoints Matthew Plunkett, Ph.D. as Chief Financial Officer by GlobeNewsWire
- Kaixin Auto Holdings Announces Myanmar Order of 1,000 EVs by GlobeNewsWire
- Metallurgical Tests at Kharmagtai Show Strong Sulphide Rougher Flotation Recovery by GlobeNewsWire
- The Joint Corp. to Participate in the 36th Annual Roth Conference by GlobeNewsWire
- Plantify Foods Secures New Retail Chain to Sell Its Plant-Based Clean Label Products by GlobeNewsWire
- Completion of Placement to Zijin Mining by GlobeNewsWire
- EQS-News: Pecan Energies, exploitant du bloc Deepwater Tano/Cape Three Points (DWT/CTP), achève le rebranding, en s’engageant à débloquer la prospérité pour le Ghana et au-delà by EQS Group AG
- MariMed’s Betty’s Eddies™ Introduces Ache Away Eddies PM For Those Who Chews A Pain-Free Night’s Sleep by GlobeNewsWire
- Jasper Therapeutics Reports Fiscal 2023 Financial Results and Recent Corporate Developments by GlobeNewsWire